Microbiology & Pathology in North Carolina

Novex Innovations is a contract development and manufacturing organization (CDMO) specializing in the design, development, and commercialization of biologics, pharmaceuticals, medical devices, and bioengineered tissue. Operating a 36,000 square-foot cGMP-compliant facility with Class 100 and Class 1,000 cleanroom spaces, the company provides comprehensive services spanning product and process development, clinical and commercial manufacturing, regulatory support, and distribution. Capabilities include biological formulations, clinical formulation, tissue processing, active pharmaceutical development, diagnostic materials manufacturing, and inventory management. ISO 13485 certified and FDA-registered, Novex supports clients from proof-of-concept through all phases of clinical trials to commercial scale-up and market distribution, serving both startups and multinational organizations across national and international markets.

Cedarlane specializes in supplying high-quality research reagents, diagnostic antibodies, kits, chemicals, and consumables to the life science community. The company operates as a distributor providing access to over 1,400 industry-leading global life science suppliers manufacturing products across all research areas. Product offerings include antibodies, arrays, assays and ELISA kits, cell lines, cloning reagents, enzymes, equipment, isotype controls, media and cell culture products, molecular biology products, primary cells, proteins and peptides, small molecules/inhibitors, transfection/transformation reagents, lab animal supplies, microbiology products, and specialty chemicals. Cedarlane serves academic institutions, research centers, universities, and diagnostic laboratories across North America. The company is part of TCP Analytical, a portfolio of chemical, research reagent, and laboratory product companies operating in the USA and Canada. Cedarlane emphasizes convenience to customers by handling import/regulatory issues and providing technical support alongside online ordering capabilities. The company maintains a customer-focused approach with dedicated technical service teams and streamlined e-commerce operations.

SARSTEDT AG & Co. KG is a global manufacturer and distributor of laboratory consumables and sample-handling products for clinical diagnostics, life science research, and laboratory automation. The company operates four primary business divisions: preanalytics (blood, urine, fecal, and saliva collection systems and accessories), life science (liquid handling, cell culture, molecular biology, sample handling, and microbiology products), sample transport (diagnostic sample containers compliant with ADR/RID and IATA dangerous goods regulations), and laboratory automation (modular automation solutions for diagnostic laboratories with over 25 years of development experience). SARSTEDT's product portfolio includes screw-cap micro tubes (0.5–2.0 ml), reagent and centrifuge tubes, serological pipettes, micro test plates, cell culture flasks, Monovette® blood collection tubes, Microvette® capillary collection devices, and Urine Monovette® collection systems. Products are manufactured to stringent quality standards, certified as sterile, non-pyrogenic, endotoxin-free, non-cytotoxic, and free from DNA/DNase/RNase contamination. The company maintains over 13 production facilities and 30 sales organizations worldwide. SARSTEDT serves clinical laboratories, medical practices, research institutions, and diagnostic facilities. The company emphasizes user-focused design, safety, reproducibility, and compliance with international regulatory requirements.

Greiner Bio-One International GmbH is a global manufacturer of biotechnology, diagnostics, and medical device solutions serving clinical laboratories, research institutions, and in vitro diagnostics markets. With headquarters in Kremsmünster, Austria, and a US presence, the company operates 28 subsidiaries and manufacturing sites across Austria, Germany, Hungary, the United States, Brazil, and Thailand, employing over 2,300 staff. The company specializes in preanalytical and bioanalytical solutions, including venous and capillary blood collection systems, urine collection containers, and safety blood collection devices. Their VACUETTE® EVOPROTECT line represents next-generation safety blood collection technology. Greiner Bio-One also manufactures comprehensive laboratory consumables: sterile syringes, needles, IV sets, collection tubes, and sample handling equipment. In bioscience research, they supply cell culture products (including 3D magnetic cell culture solutions), microplates, cryopreservation systems, and high-throughput screening (HTS) imaging microplates designed for drug discovery and ADME studies. Their portfolio includes specialized products for mass cell culture and advanced research applications. The company emphasizes safety, quality, and sustainability; they have achieved ACT Ecolabel certification for over 127 products, reflecting eco-conscious manufacturing. Greiner Bio-One serves research laboratories, clinical diagnostics facilities, blood banks, and pharmaceutical/biotech companies globally. The organization maintains strong regulatory compliance and participates actively in international scientific conferences and laboratory diagnostic forums.

Springside Scientific LLC is a Durham, NC-based laboratory services provider specializing in the manufacture and curation of custom human tissue control slides for pathology, immunohistochemistry (IHC), and diagnostic applications. The company operates a 3,500 sq ft laboratory facility and maintains an extensive tissue repository of over 40,000 tissue blocks, enabling rapid fulfillment of routine orders and same-day shipping. Core capabilities include custom control slide preparation, IHC microarrays, tailored tissue placement and selection, and comprehensive pathology reporting. The company's leadership includes two PhD-level scientists. Springside also offers private-label and white-label programs for dealers and distributors, allowing partners to brand custom-designed or co-developed tissue control products under their own labels. The company supports research institutions, diagnostic laboratories, and commercial pathology operations with quality-assured control materials essential for assay validation, quality control, and regulatory compliance in clinical and research pathology workflows.

Cancer Diagnostics, Inc. (CDI) is a specialized manufacturer and supplier of anatomical pathology products serving the global surgical pathology, histology, cytology, and immunohistochemistry markets. Founded in 1998, CDI developed the first commercially available 7-dye color kit for cancer margin identification and has grown to serve over 6,000 customers worldwide. The company manufactures a comprehensive range of histology consumables and equipment including tissue marking dyes, microtome blades (Katana™ brand), trimming knives, embedding supplies, ceramic base molds, stainers, embedding centers, slide printers, paraffin dispensers, fixatives, and tissue processing equipment. CDI operates under FDA CGMP standards and is recognized as one of the industry's largest providers of anatomical pathology supplies, supporting surgical specimen preparation, tissue processing, and diagnostic analysis workflows in hospital and independent laboratories globally.